QRxPharma Limited

Sponsored ADR (1 ADS : 5 Ordinary) International Reporting
Pink Current Information
Contact Info
  • Level 11, Suite 1
  • North Sydney, NSW 2060
  • Australia

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Latest Report Mar 31, 2016 Quarterly Report
CIK 0001433008
Fiscal Year End 6/30
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Australia
Year of Inc. 2002
Employees Not Available
Company Officers/Contacts
Chris J. Campbell CFO, Secretary
Company Directors
Bruce Hancox
Richard Treagus
Service Providers
Accounting/Auditing Firm

Not Available
Securities Counsel

Not Available
Investor Relations Firm

Not Available
QRXPY Security Details Other Company Securities
Share Structure
Market Value1 $328,382 a/o Mar 24, 2017
Authorized Shares Not Available
Outstanding Shares 164,190,969 a/o Nov 10, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 164,190,969 a/o Nov 10, 2014
Par Value No Par Value
Transfer Agent(s)
JPMorgan Depositary Receipts
Shareholders of Record Not Available
Non US Stock Exchange Listing
QRX - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Apr 30, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security